Letrozole is an antiestrogen that is an orally active, nonsteroidal and selective third-generation aromatase inhibitor. It was first discovered in the 1980’s by swiss scientists screening compounds for their aromatase inhibiting abilities. Letrozole therapy is particularly relevant in treating hormone receptor-positive breast cancer, as it effectively suppresses estrogen levels and improves patient outcomes. It inhibits […]
